18F-FDG PET/CT for Staging and Restaging of Breast Cancer
Authors:
- 1 February 2016
- journal article
- review article
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 57 (Supplement) , 17S-26S
Abstract
Many studies have pointed out the role of 18F-FDG PET/CT (or 18F-FDG PET) in patients with clinical stage III or II breast cancer. 18F-FDG PET/CT might advantageously replace other staging procedures, such as bone scanning and possibly contrast-enhanced CT of the thorax or abdomen–pelvis. We discuss the findings, locoregional or distant, that can be expected in different categories of breast cancer and their impact on prognosis and management. We also discuss the role of 18F-FDG PET/CT in restaging and how 18F-FDG PET/CT compares with conventional techniques in restaging for patients with suspected disease recurrence. We conclude with some recommendations for clinical practice and future research.Keywords
This publication has 55 references indexed in Scilit:
- Additional value of F-18 FDG PET/CT for initial staging in breast cancer with clinically negative axillary nodesBreast Cancer Research and Treatment, 2014
- Pretreatment Staging Positron Emission Tomography/Computed Tomography in Patients With Inflammatory Breast Cancer Influences Radiation Treatment Field DesignsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Prospective Study of 2-[18F]Fluorodeoxyglucose Positron Emission Tomography in the Assessment of Regional Nodal Spread of Disease in Patients With Breast Cancer: An Ontario Clinical Oncology Group StudyJournal of Clinical Oncology, 2012
- Positron emission tomography (PET) for assessment of axillary lymph node status in early breast cancer: A systematic review and meta-analysisEuropean Journal of Surgical Oncology, 2011
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNMAnnals of Surgical Oncology, 2010
- 18F‐fluorodeoxyglucose positron emission tomography/computed tomography (FDG‐PET/CT) imaging in the staging and prognosis of inflammatory breast cancerCancer, 2009
- Retrospective Study of 18F-FDG PET/CT in the Diagnosis of Inflammatory Breast Cancer: Preliminary DataJournal of Nuclear Medicine, 2009
- A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastasesAnnals of Oncology, 2006
- 18F-2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography in Staging of Locally Advanced Breast CancerJournal of Clinical Oncology, 2004
- Prospective Multicenter Study of Axillary Nodal Staging by Positron Emission Tomography in Breast Cancer: A Report of the Staging Breast Cancer With PET Study GroupJournal of Clinical Oncology, 2004